You have 9 free searches left this month | for more free features.

NPD

Showing 1 - 25 of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

(NPD) Protocol in Chronic Rhinosinusitis

Recruiting
  • Rhinosinusitis
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jul 18, 2022

    Cystic Fibrosis Trial in Philadelphia (Nasal potential difference measurement)

    Completed
    • Cystic Fibrosis
    • Nasal potential difference measurement
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jan 27, 2020

    New X-ray Protective Device in Coronary Interventional Therapy

    Enrolling by invitation
    • Coronary Heart Disease
      • Nanjing, Jiangsu, China
        First Affiliated Hospital of Nanjing Medical University
      Feb 2, 2022

      Cystic Fibrosis Transmembrane Regulator Biomarker Study to

      Recruiting
      • Cystic Fibrosis
      • Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor
      • Berlin, Germany
      • +3 more
      Apr 1, 2022

      Cystic Fibrosis Trial in Denver, Baltimore, Philadelphia (Ravicti low dose, Ravicti high dose, Placebo)

      Terminated
      • Cystic Fibrosis
      • Ravicti low dose
      • +2 more
      • Denver, Colorado
      • +2 more
      Mar 4, 2022

      Ivacaftor for Acquired CFTR Dysfunction in Chronic

      Active, not recruiting
      • CRS
      • EDSPD
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jun 24, 2022

      Cohort 1 : Metastatic Non Small Cell Lung Cancer, Cohort 2 : Metastatic Bladder Cancer, Cohort 3 : Metastatic Renal Cell

      Not yet recruiting
      • Cohort 1 : Metastatic Non Small Cell Lung Cancer
      • +3 more
      • Atezolizumab 60 MG/1 ML Intravenous Solution [TECENTRIQ]
      • +2 more
      • Dijon, Bourgogne, France
        Centre Georges François Leclerc (CGFL)
      Feb 18, 2022

      Cystic Fibrosis Trial in Cincinnati (CFTR Modulators)

      Recruiting
      • Cystic Fibrosis
      • CFTR Modulators
      • Cincinnati, Ohio
        CCHMC
      Apr 26, 2022

      Violence, Emotional Adjustment Trial in London (Face It, Control)

      Recruiting
      • Violence
      • Emotional Adjustment
      • Face It
      • Control
      • London, United Kingdom
      • +1 more
      Sep 25, 2023

      Cystic Fibrosis Trial in United States (Losartan, )

      Terminated
      • Cystic Fibrosis
      • Birmingham, Alabama
      • +3 more
      Nov 12, 2020

      Healthy Lifetime Non-smokers Trial in Miami (Propylene Glycol, vegetable glycerin, PG+VG)

      Terminated
      • Healthy Lifetime Non-smokers
      • Propylene Glycol
      • +2 more
      • Miami, Florida
        University of Miami School of Medicine
      Jan 10, 2020

      Activation of p.Phe508del-CFTR by Lumacaftor in Combination With

      Completed
      • Cystic Fibrosis
      • Lumacaftor plus Ivacaftor
      • Gießen, Germany
      • +2 more
      Jul 28, 2020

      Cystic Fibrosis Trial in Belgium, France, United States (QR-010)

      Completed
      • Cystic Fibrosis
      • Birmingham, Alabama
      • +4 more
      Sep 2, 2020

      A Comparison of the TIMI, GRACE, HEART and HEARTSIL Scores

      Recruiting
      • Chest Pain
      • No intervention
      • Konya, Turkey
        Konya City Hospital
      Apr 22, 2021

      COPD, Chronic Bronchitis Trial in Miami (Losartan 50 mg, Losartan 100 mg)

      Terminated
      • COPD
      • Chronic Bronchitis
      • Losartan 50 mg
      • Losartan 100 mg
      • Miami, Florida
        University of Miami
      Aug 7, 2020

      Glaucoma, Cataract Trial in Kuala Lumpur (Lignocaine-loaded maltose microneedle array patch, EMLA 5% patch)

      Not yet recruiting
      • Glaucoma
      • Cataract
      • Lignocaine-loaded maltose microneedle array patch
      • EMLA 5% patch
      • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
        Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia
      Jan 19, 2023

      Diabete Type 2, Diabetic Foot, Neuropathy, Diabetic Trial (LSCI)

      Not yet recruiting
      • Diabete Type 2
      • +4 more
      • LSCI
      • (no location specified)
      May 2, 2023

      Prostate Cancer Trial in Baltimore (robotic placement device)

      Completed
      • Prostate Cancer
      • robotic placement device
      • Baltimore, Maryland
        The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Nov 22, 2019

      Back Pain, Psychiatric Disorder Trial

      Unknown status
      • Back Pain
      • Psychiatric Disorder
        • (no location specified)
        Apr 21, 2019

        Cystic Fibrosis Trial in Denver (Sildenafil, Placebo)

        Completed
        • Cystic Fibrosis
        • Denver, Colorado
          National Jewish Health
        Mar 2, 2019

        Cystic Fibrosis Trial in Brussels (Vardenafil, Placebo)

        Terminated
        • Cystic Fibrosis
        • Brussels, Belgium
          Cliniques universitaires St. Luc
        Feb 21, 2019

        Neuroendocrine Tumours Trial in Italy (Lanreotide (Autogel formulation) and Temozolomide)

        Completed
        • Neuroendocrine Tumours
        • Lanreotide (Autogel formulation) and Temozolomide
        • Viagrande, Catania, Italy
        • +9 more
        Sep 9, 2020

        Assess Quality of Life of Consumers With Self-reported Fungal

        Unknown status
        • Onychomycosis of Toenail
        • Fungal Nail Treatment Kit
        • Hull, East Yorkshire, United Kingdom
          RB Health
        Sep 9, 2019

        Musculoskeletal Pain Trial in Glasgow (Orthotic Insole: Lower Back, Orthotic Insole: Heel, Orthotic Insole: Knee to Heel)

        Terminated
        • Musculoskeletal Pain
        • Orthotic Insole: Lower Back
        • +3 more
        • Glasgow, Scotland, United Kingdom
          CPS Research
        Feb 4, 2021

        Cystic Fibrosis Trial in France (Roscovitine, Placebo)

        Terminated
        • Cystic Fibrosis
        • Lille, France
        • +10 more
        Dec 11, 2018